
    
      This study is a randomized prospective double-blind, accomplished with sealed envelopes ,with
      two groups :

        -  Group A: Short treatment duration: 1 tablet Levofloxacin 500mg / day for two days
           completed by 1 tablet Placebo Levofloxacin 500mg / day for the remaining 5 days.

        -  Group B: Standard treatment duration (control group): 1 tablet Levofloxacin 500mg / day
           for 7 days.

      The study is conducted by recruiting AECOPD patients to collect their blood samples and
      sputum samples. These samples will be used for the inflammatory analyses and the study of
      bacterial and viral serology. The results were seized by the SPSS.20.0 software.
    
  